Clorox Q4 adj EPS $2.87 (+58% YoY); organic sales +8% on ERP pull-forward; provides FY26 outlook

CLOROX CO /DE/

2025-FY EPS reported $6.52 vs consensus $1.45 ▲ beat (+350.4%)

Q4 net sales $2.0B (+4% GAAP, +8% organic); incremental ERP shipments contributed ~13-14 points to sales.
Q4 adj EPS $2.87 vs $1.82 (+58%), including ~$0.85-0.95 benefit from ERP shipments.
FY25 free cash flow $761M (10.7% of sales) vs $483M (6.8%) prior year; capex $220M.
FY25 gross margin expanded 220 bps to 45.2% driven by cost savings of 190 bps.
Management notes topline below expectations in H2; FY26 outlook provided but no specific numbers in release.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.